We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In a bid to "advance opportunities" in cell and gene therapy, the FDA intends to unveil additional new policy guidance and other progress made in its drug development framework this year.